
    
      The aim of the study is to assess the safety and efficacy of elective deployment of the
      Sirolimus-eluting Coroflex ISAR Stent for the treatment of "real world" de-novo and
      restenotic lesions after stand-alone angioplasty in coronary arteries of 2.0 mm up to 4.0 mm
      in diameter and up to 30 mm in length for procedural success and preservation of vessel
      patency.
    
  